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ABSTRACT
BindingDB (http://www.bindingdb.org) is a publicly
accessible database currently containing 20000
experimentally determined binding affinities of
protein–ligand complexes, for 110 protein targets
including isoforms and mutational variants, and
11000 small molecule ligands. The data are
extracted from the scientific literature, data collec-
tion focusing on proteins that are drug-targets or
candidate drug-targets and for which structural data
are present in the Protein Data Bank. The BindingDB
website supports a range of query types, including
searches by chemical structure, substructure and
similarity; protein sequence; ligand and protein
names; affinity ranges and molecular weight. Data
sets generated by BindingDB queries can be down-
loaded in the form of annotated SDfiles for further
analysis, or used as the basis for virtual screening
of a compound database uploaded by the user. The
data in BindingDB are linked both to structural data
in the PDB via PDB IDs and chemical and sequence
searches, and to the literature in PubMed via
PubMed IDs.
INTRODUCTION
The early steps in a modern drug discovery project typically
include identifying a biological macromolecule that plays
a key role in a disease process, and seeking a low-molecular
weight compound that inactivates this macromolecular target
by binding it with high afﬁnity. Ligand discovery involves
a substantial component of trial and error, despite advances
in computer-aided drug-design, so many binding data are
generated for each target. Projects directed at ligand discov-
ery therefore generate large quantities of binding data not
only for drugs, but also for compounds that do not themselves
become drugs. When published, these data become a valuable
resource for scientists studying the same macromolecular tar-
get, and also for those seeking to develop improved computa-
tional models of molecular recognition.
Currently, binding data are published almost exclusively
via the scientiﬁc journals, which provide an indispensable
archival service, are now available in electronic formats, and
can be searched in useful ways. However, the journals also
impose severe restrictions, as recently emphasized (1). For
example, they provide no mechanism for accessing data in
numerical form, querying according to chemical structure,
downloading computer representations of chemical structure,
publishing large datasets in any detail or navigating among
binding, structural and sequence data. By providing these
missing functionalities, especially to researchers in academia
and in small companies who do not have access to the
resources of the major pharmaceutical ﬁrms, a database of
measured binding afﬁnities should accelerate the discovery
of targeted ligands. Potential applications of a binding data-
base include:
(1) Analysis of ligands for a specific target to discover
chemical features or pharmacophores that correlate with
affinity.
(2) Development of quantitative structure–activity relation-
ships.
(3) Interpretation of measured entropies and enthalpies of
binding in the context of a receptor’s 3D structure.
(4) Parameterization and validation of broadly applicable
methods of ligand design.
(5) Identification of candidate lead compounds for a new
drug target, by searching for ligands known to bind
similar proteins.
(6) Identification of drug candidates with a high risk of side
effects, by checking whether similar compounds bind
multiple receptors.
(7) Elucidation of the mechanism of a biological effector
molecule; e.g. if a naturally occurring compound inhibits
cellular proliferation, a search of the database for
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A binding database also offers the possibility of publishing
data that are not amenable to journal publication, such as very
large data sets, and raw experimental data which can be use-
ful in the assessment of data quality.
BindingDB (http://www.bindingdb.org) was created to
address these needs. It currently holds 20000 measure-
ments, making it one of the most extensive public databases
of protein–ligand binding afﬁnities, and it is continuing to
grow. The present paper summarizes these data holdings as
well as new website features and capabilities; basic technical
aspects of BindingDB have been described previously (2–4).
CONTENTS OF THE DATABASE
Data collection currently focuses on targets whose three-
dimensional structures are available in the Protein Data
Bank (5,6) (PDB) or can be accurately modeled. Such data
are of particular interest because they are amenable to struc-
tural analysis and are suitable for the development and vali-
dation of computational models of binding. Statistical
sampling of the PDB in 2003 revealed that 150 of the
non-redundant proteins therein were considered current or
potential drug-targets (unpublished data) and were thus suita-
ble for data collection by BindingDB. This analysis omits
additional drug-targets whose structures could be built by
comparative modeling. Restricting attention to proteins of
known structure allows BindingDB to complement, rather
than overlap, other binding databases collecting data for
membrane proteins whose 3D structures are, in the main, una-
vailable; e.g. GPCRDB [www.gpcr.org (7)], the IUPHAR
receptor database (www.iuphar-db.org) and GLIDA [http://
gdds.pharm.kyoto-u.ac.jp/services/glida/index.php (8)].
Proteins are selected for data collection based upon their
importance as drug-targets or model systems, as well as the
availability of suitable data. Once a protein is selected, relev-
ant scientiﬁc articles are identiﬁed and their data are extracted
and deposited into BindingDB. Data from multiple laborator-
ies and companies are sought in order to obtain a wide range
of chemotypes for the targeted protein. The journals from
which data are drawn include J. Med. Chem., Bioorg. Med.
Chem. Lett. and Biochem. Web-accessible forms also allow
direct deposition by experimentalists, but this route has not
generated a signiﬁcant number of entries. The majority of
the data are based upon enzyme inhibition studies (>19000
measurements), but a smaller number of data from the more
informative method of isothermal titration calorimetry also
are included (416 measurements). Each data entry includes
detailed experimental conditions, such as solution composi-
tion, pH and temperature, because these can affect the meas-
ured afﬁnities.
BindingDB currently holds 20000 binding data for
11000 different small molecule ligands and 110 different
drug-targets; or 74 targets when mutants and isoforms are
not counted separately. Examples include anthrax lethal fac-
tor, various caspases and kinases and HIV protease and
reverse transcriptase. Perhaps the most similar public effort
is KiBank (9), which provides a sparser user-interface to
a substantial data set of 16000 Ki data for 5900 small
molecule ligands and 50 protein targets, apparently including
proteins for which no structural data are available. For a per-
spective on BindingDB’s current data holdings, Figure 1
shows the number of binding measurements for various tar-
gets and target classes, and Figure 2 provides histograms of
Ki and IC50 values, and of the molecular weights of the
small molecules across all entries. Although structural data
are available for every protein target included in BindingDB,
BindingDB collects data for many ligands that are not repres-
ented in the PDB. For example, the PDB has 50 structures
of acetylcholinesterases, while BindingDB has afﬁnity data
for acetylcholinesterase with 250 different ligands. More
generally, 2% of ligands in BindingDB have an exact
match in the PDB and 15% of ligands in BindingDB
have 90% similarity to a ligand in the PDB based upon the
search criterion of the PDB. Thus, BindingDB’s data collec-
tion differs signiﬁcantly from those of databases which only
collect afﬁnities for protein–ligand complexes in the PDB,
notably BindingMOAD (10) which holds 1400 data,
PDBBind (11,12) with 1600 data, and AfﬁnDB (13) with
750 data.
WEB INTERFACE: QUERY, DOWNLOAD AND
VIRTUAL COMPOUND SCREENING
The BindingDB website provides an increasingly rich set of
tools for query, analysis and download of binding data.
Search capabilities include queries by target name; ligand
name; afﬁnity range; chemical structure, substructure and
similarity; and target sequence, via BLAST (14). Query res-
ults are presented in a summary table, with the option to drill
down to more detail on a given measurement. Available
details include citation data, with links to PubMed and the
option to retrieve all binding data from the same publication;
sequence data and SMILES strings (15,16) and chemical
Figure 1. Number of measurements in BindingDB for various targets and
target classes.
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structural data for a given ligand, protein or complex. Addi-
tional tools also allow the user to build a ‘data set’ which can
be downloaded in the form of an MDL SDﬁle containing
chemical structures, target information and afﬁnities.
The website also provides web-accessible tools for virtual
screening of candidate ligands; we are not aware of any other
public website that provides this functionality. The user pro-
vides a training set of ligands active against a given target or
class of targets, either by using queries to form a BindingDB
data set, or by uploading an SDﬁle from disk. The user then
uploads his or her own SDﬁle of candidate ligands, selects
one of three machine-learning methods installed on the Bin-
dingDB server, and starts the calculation. The software returns
a ranking of the user’s candidate ligands, where the top-
ranked compounds are most likely to share the activity of
the training set of active compounds. The results can be
downloaded in the form of an SDﬁle containing the score of
each compound; optionally, the compounds in the SDﬁle can
be ranked according to their scores. The three machine-
learning methods are as follows.
Maximum similarity
JChem (17) chemical ﬁngerprints are computed with default
parameters for each active compound and for each candidate
ligand. The software computes the Tanimoto similarity [see,
e.g. (18)] of each candidate compound to each active, and
ranks the candidate compounds according to their maximal
similarity to any active.
Binary kernel discrimination
JChem chemical ﬁngerprints are computed with default para-
meters for each active compound and for a set of decoy com-
pounds that are presumed to be inactive. The decoy
compounds can be supplied by the user, or BindingDB can
supply a random set of drug-like compounds drawn from
the Zinc compound database (19). The BKD method (20) is
then trained on a subset of the known actives and decoys,
and tested on the remainder of the actives and decoys. The
results of the test are reported to the user in terms of the fold
enrichment of the known actives among the top 2% and top
10% of the ranked test-set compounds. If a high degree of
enrichment is obtained (e.g. 10-fold enrichment) then it is
reasonable to screen the user’s candidate ligands with the
trained model. When the user uploads these compounds,
JChem ﬁngerprints are computed for them, and the com-
pounds are scored and ranked. The scores of the candidate
ligands can be compared with those of the test-set actives
and decoys, which are also provided as part of the output.
Support vector machine
As for the BKD, a set of active compounds and a set of
decoys is established. The user is then presented with a list
of quantitative molecular descriptors that can be used for
the screening process; a reasonable default set of these is sug-
gested by the website in order to aid the user. Descriptors are
computed for all the compounds with Molconn-Z (eduSoft
LC), and the descriptor set is then reﬁned to avoid using
highly correlated, and therefore redundant, descriptors (21).
The LibSVM software (22) is then trained with a subset of
the actives and decoys, and applied to the remaining active
and decoy compounds to generate training set and test-set
rankings, as previously described (21). The quality of these
results are reported as enrichment factors, as for the BKD,
and the user can then upload an SDﬁle of compounds to be
ranked with the trained SVM model.
Maximum similarity is the fastest of the three methods and
thus may be most convenient for very large screening sets.
The BKD method is slower, but can recover more diverse
actives. The SVM method also is slower than maximum
Figure 2. Histograms of binding affinities (1 M standard concentration), and molecular weights of ligands in BindingDB.
D200 Nucleic Acids Research, 2007, Vol. 35, Database issuesimilarity, but is arguably the best at ﬁnding actives that dif-
fer signiﬁcantly from the known actives used to train the
algorithm.
AVAILABILITY AND CITATION
BindingDB is freely accessible at http://www.bindingdb.org,
and also may be accessed by following links from compounds
at PubChem. To download SDﬁles, users must complete
a simple registration process and agree not to republish the
data without explicit permission. Users are invited to contact
us through the ‘Email us’ link and to participate in the user-
forum at http://www.bindingdb.org/forum/forum.jsp. Sugges-
tions regarding data sets to be extracted and deposited in
BindingDB, and for web site features, are welcomed. Works
using BindingDB should cite references (2–4) in this paper.
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